Dr. F. Helm, Allan Ellison, J. Murie, P. L. Sclater, H. Goss, J. A. Harvie Brown, T. E. Buckley,
... Buckley. …, Entomological Society of London, The Badger, Meles Taxus Plate I, The Garden Dormouse, Myoxus Quercinus, Scientific ...
1888 - Gale Group | NCCO-STM 1of2
Priyanka Adhikari, Kuldeep Joshi, Anita Pandey,
... plants under stressed environments. While various species of Taxus have been globally recognized mainly due to their ... the taxonomic (endangered) status of the species. Furthermore, Taxus associated endophytes are also being recognized for the ... production. The present study reviews the diversity of Taxus associated endophytes along with their biological activities. Available literature on Taxus associated endophytes revealed that T. chinensis has received ... diverse endophytic species have been reported from different Taxus species. Fusarium sp. (25.2 %), Aspergillus sp. (17. ...
Tópico(s): Fungal Biology and Applications
2023 - Elsevier BV | Fungal Biology Reviews
Derya Evrim Koç, Jens‐Christian Svenning, Meral Avcı,
... by future climate change. One such species is Taxus baccata. Taxus baccata, which is distributed throughout the temperate zones of Northern hemisphere, is the only species of Taxus to be naturally distributed in Turkey. Apart from ... general dispersal area in the north of Turkey, Taxus baccata is seen in small groups in protected ... and future climate change on the distribution of Taxus baccata in Bolkar Mountains, using species distribution modelling. ... Maxent is used for determining the distribution of Taxus baccata. Our Maxent model results show that the ...
Tópico(s): Forest Insect Ecology and Management
2018 - | Eurasian Journal of Forest Science
Ehrin J. Armstrong, John C. Rutledge, Jason H. Rogers,
... but instead uses the Synergy Between PCI With TAXUS and Cardiac Surgery (SYNTAX) score to stratify decision ... eluting stent; and SYNTAX, Synergy Between PCI With TAXUS and Cardiac Surgery.The BARI trial compared the ... 47The SYNTAX study examined the use of the TAXUS paclitaxel-eluting stents (PES) versus CABG for the ... in DMOutcome in DMSPIRIT V2006–2007Xience EES vs TAXUS PES218 EES106 PES324 (100)1In-stent late lossPES ... DM and non-DMNAPLES-DIABETES2005–2007E-ZES vs TAXUS PES vs Cypher SES75 ZES75 PES76 SES226 (100) ...
Tópico(s): Cardiac and Coronary Surgery Techniques
2013 - Lippincott Williams & Wilkins | Circulation
John A. Ormiston, O’Shaughnessy Charles, Tift Mann, Jack Hall, Thomas McGarry, Louis Cannon, Mark Webster, Gregory Mishkel, Paul Underwood, Keith D. Dawkins,
... the final, cumulative, 5-year outcomes from the TAXUS ATLAS program, which studied the use of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions.TAXUS ATLAS Workhorse, Small Vessel, and Long Lesion are nonrandomized studies comparing TAXUS Liberté (N=871), TAXUS Liberté 2.25 mm (N=261), and TAXUS Liberté 38 mm (N=150) stents, respectively, with ...
Tópico(s): Cardiac Imaging and Diagnostics
2012 - Lippincott Williams & Wilkins | Coronary Artery Disease
Kohei Wakabayashi, Ron Waksman, Neil J. Weissman,
... the Cypher sirolimus-eluting stent (SES) (Cordis), the Taxus paclitaxel-eluting stent (PES) (Boston Scientific), the Endeavor ... the stent edge if available.Paclitaxel-Eluting StentsThe TAXUS II trial10 studied the vessel response of the ... and slow-release groups (P=0.03).The TAXUS IV, TAXUS V, and TAXUS VI trials11,12 were prospective, multicenter, randomized studies ... IVUS subgroup was prespecified in each trial. The TAXUS IV trial11 confirmed and expanded the results from TAXUS II, showing no aggravation of edge stenosis. Nonetheless, ...
Tópico(s): Cerebrovascular and Carotid Artery Diseases
2012 - Lippincott Williams & Wilkins | Circulation Cardiovascular Interventions
Marcel A.M. Beijk, Margo Klomp, Nan van Geloven, Karel T. Koch, José P.S. Henriques, Jan Baan, Marije M. Vis, Jan G.P. Tijssen, Jan J. Piek, Robbert J. de Winter,
... progenitor cell capturing stent was compared with the Taxus Liberté™ SR paclitaxel-eluting stent. At 1 yr, ... were randomized to a Genous stent versus a Taxus stent. Dual antiplatelet therapy was prescribed for ≥1 ... stent implantation and for ≥6 months after a Taxus stent.Between 1 and 2 yr, patients treated ... 0% versus 1.1%) when compared with the Taxus stent. As a result, at 2-yr follow- ... treatment with the Genous stent compared with the Taxus stent resulted in a nonsignificant difference in target ... to five cases (in four patients) in the Taxus group, resulting in a difference as compared with ...
Tópico(s): Cerebrovascular and Carotid Artery Diseases
2011 - Wiley | Catheterization and Cardiovascular Interventions
Vasim Farooq, Bill D. Gogas, Patrick W. Serruys,
... diameter stenosis (C, D) after Cypher (left) and Taxus (right) implantation. LLL indicates late lumen loss. Reproduced ... the Moderate Vein Graft Lesion Stenting With the Taxus Stent and Intravascular Ultrasound (VELETI) pilot trial,31 ... with 4 different types of DES (Endeavor, SES, Taxus Express, and Liberte) in real-world practice at ... vessels, respectively), compared with 20% to 25% with Taxus (10% to 20% and 2.5% to 7. ... A fairer comparison perhaps would be between the Taxus Liberte and Express because both are identical except ...
Tópico(s): Cardiac Imaging and Diagnostics
2011 - Lippincott Williams & Wilkins | Circulation Cardiovascular Interventions
Neil J. Weissman, Mark Turco, John A. Ormiston, Tift Mann, Louis Cannon, Thomas McGarry, Mark Webster, Jack Hall, Michael J. Lucca, Gregory Mishkel, Chiung‐Jen Wu, Lazar Mandinov, Keith D. Dawkins,
... evaluate the vascular response of the thin-strut TAXUS Liberté stent compared with the otherwise identical TAXUS Express stent. The TAXUS ATLAS and TAXUS ATLAS Long Lesion studies are nonrandomized trials comparing the thin-strut TAXUS Liberté stent to historical TAXUS Express controls from the TAXUS IV and TAXUS V trials. A total of 377 patients enrolled ...
Tópico(s): Cardiac Valve Diseases and Treatments
2010 - Elsevier BV | Cardiovascular revascularization medicine
Dean J. Kereiakes, Louis Cannon, Robert L. Feldman, Jeffrey J. Popma, Raymond D. Magorien, Robert Whitbourn, Ira Dauber, Abram C. Rabinowitz, Michael W. Ball, Barry Bertolet, Ameer Kabour, Michael Foster, John Wang, Paul Underwood, Keith D. Dawkins,
... safety and efficacy of the novel platinum chromium TAXUS Element paclitaxel-eluting stent (PES) compared with the TAXUS Express PES (Boston Scientific, Natick, Massachusetts) in treating coronary artery stenoses. The TAXUS Element is a novel thin-strut (81 μm), ... Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) Workhorse (WH) ... randomized (3:1), controlled, multicenter study of the TAXUS Element (vs. TAXUS Express) PES for the treatment of de novo ... The study was powered to demonstrate noninferiority to TAXUS Express for both end points. The intent-to- ...
Tópico(s): Cardiac Imaging and Diagnostics
2010 - Elsevier BV | Journal of the American College of Cardiology
Dominic J. Allocco, Louis Cannon, Amy Britt, John Heil, Andrey Nersesov, Scott Wehrenberg, Keith D. Dawkins, Dean J. Kereiakes,
... percutaneous coronary intervention compared to bare metal stents. TAXUS Element is a third-generation paclitaxel-eluting stent ... eluting stents. The safety and efficacy of the TAXUS Element stent are being evaluated in the pivotal ... PERSEUS trials include two parallel studies of the TAXUS Element stent in single, de novo coronary atherosclerotic ... 75 mm to ≤4.0 mm which compares TAXUS Element to the TAXUS Express 2 paclitaxel-eluting stent system. The Workhorse ... a safer and more efficient analysis of the TAXUS Element stent. PERSEUS Small Vessel is a prospective, ...
Tópico(s): Cardiac Imaging and Diagnostics
2010 - Springer Science+Business Media | Trials
Daniel Steinberg, Gary S. Mintz, Lazar Mandinov, Alan S.L. Yu, Steven G. Ellis, Eberhard Grube, Keith D. Dawkins, John A. Ormiston, Mark Turco, Gregg W. Stone, Neil J. Weissman,
... acquired ISA in bare-metal stents (BMS) and TAXUS stents (Boston Scientific, Natick, Massachusetts) is debatable. We ... enrolled in the intravascular ultrasound (IVUS) substudies of TAXUS IV, V, VI and TAXUS-ATLAS WH, LL, and DS trials. There were ... 26 (7.2%) BMS patients, 35 (9.7%) TAXUS Express patients (p = 0.28 vs. BMS), and 35 (7.3%) TAXUS Liberté patients (p = 0.21 vs. TAXUS Express, and p = 1.00 vs. BMS). Major ... vs. 15.2%, p = 0.13) and for TAXUS (11.6% vs. 8.8%, p = 0.45). ... 7%) BMS patients, 17 (3.1%) patients with TAXUS slow-release (TAXUS Express or TAXUS Liberté), and ...
Tópico(s): Aortic aneurysm repair treatments
2010 - Elsevier BV | КАРДИОЛОГИЯ УЗБЕКИСТАНА
Eberhard Grube, Keith D. Dawkins, Giulio Guagliumi, Adrian Banning, Krzysztof Żmudka, Antonio Colombo, Leif Thuesen, Karl Hauptman, Jean Marco, William Wijns, Anita Joshi, Stephen R. Mascioli,
... term safety and efficacy of the paclitaxel-eluting TAXUS moderate-release (MR) investigation-only stent for the treatment of long, complex coronary artery lesions.TAXUS VI was a prospective, double-blind, multicentre trial wherein 446 patients were randomised between a TAXUS Express MR stent and an uncoated Express Control ... 27.8% in control and 31.3% in TAXUS (P = 0.61), including similar rates for stent ... 23.7% in control and 22.2% in TAXUS (P = 0.45) with a non-target lesion ... 5.1% in control and 10.9% in TAXUS (P = 0.0274) and a TLR rate of ...
Tópico(s): Cerebrovascular and Carotid Artery Diseases
2009 - European Association of Percutaneous Cardiovascular Interventions | EuroIntervention
Bernard Chevalier, Sigmund Silber, Seung‐Jung Park, Eulogio Garcı́a, Gerhard Schüler, Harry Suryapranata, Jacques Koolen, Karl E. Hauptmann, William Wijns, Marie‐Claude Morice, Didier Carrié, Gerrit‐Anne van Es, Hirofumi Nagai, Danny Detiege, Dragica Paunovic, Patrick W. Serruys,
... eluting stent Nobori and the paclitaxel-eluting stent Taxus Liberté, in 243 patients (153 Nobori and 90 Taxus) at 29 centers in Europe, Asia, and Australia. ... lower in the Nobori group compared with the Taxus group (0.11�0.30 mm versus 0. ... primary hypothesis of noninferiority of Nobori stent versus Taxus Liberté stent ( P <0.001) and the secondary ... reduction in binary restenosis from 6.2% in Taxus to 0.7% in Nobori ( P =0.02) ... intravascular ultrasound, from 5.5�7.2% in Taxus to 1.8�5.2% in Nobori ( P = ... in the Nobori and 5.6% in the Taxus cohort of patients. The stent thrombosis rate was ...
Tópico(s): Cerebrovascular and Carotid Artery Diseases
2009 - Lippincott Williams & Wilkins | Circulation Cardiovascular Interventions
Sigmund Silber, Antonio Colombo, Adrian Banning, Karl Eugen Hauptmann, J Drzewiecki, Eberhard Grube, Dariusz Dudek, Donald S. Baim,
Background— The TAXUS II trial was designed to evaluate the safety and efficacy of the commercialized slow-release (SR) and an investigation-only moderate-release (MR) polymer-based TAXUS paclitaxel-eluting stent compared with a bare-metal ... 536 patients in 2 consecutive cohorts to compare TAXUS SR (n=131) and TAXUS MR (n=135) with an identical but uncoated ... analysis reports final 5-year clinical outcomes of TAXUS II. At 5 years, both TAXUS SR and MR showed superior outcomes compared with ... 4.5% ( P <0.001) for the control, TAXUS SR, and TAXUS MR groups, respectively. The rates ...
Tópico(s): Antiplatelet Therapy and Cardiovascular Diseases
2009 - Lippincott Williams & Wilkins | Circulation
Michael Mæng, Lisette Okkels Jensen, Anders Galløe, Per Thayssen, Evald Høj Christiansen, Knud Nørregaard Hansen, Steffen Helqvist, Hans Erik Bøtker, Jens Flensted Lassen, Leif Thuesen,
... of sirolimus-eluting Cypher stents and paclitaxel-eluting Taxus stents in patients with diabetes. The study was ... disease were randomized to Cypher (n = 76) or Taxus (n = 77) stent implantation. All patients were followed ... reduced in the Cypher group compared with the Taxus group (0.23 ± 0.54 vs 0.44 ± ... was present in 16 patients (Cypher, n = 6; Taxus, n = 10; p = 0.24). Target lesion revascularization ... 9 patients (11.8%) in the Cypher and Taxus groups, respectively (p = 0.25). Definite stent thrombosis was observed in 2 patients (in the Taxus group), no patients had probable stent thrombosis, and ...
Tópico(s): Antiplatelet Therapy and Cardiovascular Diseases
2008 - Elsevier BV | The American Journal of Cardiology
Mark Turco, John A. Ormiston, Jeffrey J. Popma, Jack Hall, Tift Mann, Louis Cannon, Mark Webster, Gregory Mishkel, Charles O’Shaughnessy, Thomas McGarry, Lazar Mandinov, Keith D. Dawkins, Donald S. Baim,
The TAXUS ATLAS Small Vessel (SV) and Long Lesion (LL) multicenter studies compared the performance of the thin-strut (0.0038 inch) TAXUS Liberté 2.25-mm stent (Boston Scientific; Natick, Massachusetts) and the TAXUS Liberté 38-mm long stent (Boston Scientific; Natick, Massachusetts) with the earlier paclitaxel-eluting TAXUS Express (Boston Scientific) stent that has identical polymer, ... geometry and thicker struts (0.0052 inch). The TAXUS Liberté stent was designed with thinner and more ... new stent design have not been evaluated. The TAXUS ATLAS SV and LL studies are nonrandomized studies ...
Tópico(s): Cardiac Valve Diseases and Treatments
2008 - Elsevier BV | КАРДИОЛОГИЯ УЗБЕКИСТАНА
Jian Liu, Akiko Maehara, Gary S. Mintz, Neil J. Weissman, Alan S.L. Yu, Hong Wang, Lazar Mandinov, Jeffrey J. Popma, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, Gregg W. Stone,
... intravascular ultrasound data after stent implantation from the TAXUS IV, V, and VI trials to determine predictors of angiographic stent edge restenosis. In the combined TAXUS IV, V, and VI trials, intravascular ultrasound was ... 2.4%) had distal edge angiographic restenosis; 14 TAXUS stents (5.2%) had proximal edge and 1 TAXUS stent (0.4%) had distal edge angiographic restenosis. ... in the overall cohort and in BMS- and TAXUS-treated patients separately, only edge plaque burden was ... c = 0.70, p = 0.0244) and in TAXUS-treated patients (cutoff 47.1%, c = 0.69, ...
Tópico(s): Cerebrovascular and Carotid Artery Diseases
2008 - Elsevier BV | The American Journal of Cardiology
Gregg W. Stone, Stephen G. Ellis, Antonio Colombo, Eberhard Grube, Keith D. Dawkins, Mark I. Friedman, Donald S. Baim,
... on the basis of the prospective, double-blind TAXUS-II SR, TAXUS-IV, and TAXUS-V trials. Of 2,736 randomized patients, 2, ... the 1,141 event-free patients randomized to Taxus stents, a trend was present in those patients ... respectively, p = 0.43). However, in event-free Taxus patients taking compared with those not taking thienopyridines ... 1-year thienopyridine use status and stent type (Taxus vs bare-metal stent) on the individual or ... on the basis of the prospective, double-blind TAXUS-II SR, TAXUS-IV, and TAXUS-V trials. ...
Tópico(s): Cardiac Imaging and Diagnostics
2008 - Elsevier BV | The American Journal of Cardiology
The current natural distribution of Taxus taccata L. in Belgium is limited to a few localities in the southern part of the country. In these localities, Taxus is predominantly growing on steep, calcareous slopes, which ... world. In Flanders, the northern part of Belgium, Taxus is considered not to be native and Taxus stands are interpreted there as being planted by ... escapes. The Holocene pollen and macrofossil data for Taxus, however, show a very different picture regarding abundance ... habitat. It appears that during the Sub-boreal, Taxus grew in the coastal plain and the lower ...
Tópico(s): Geology and Paleoclimatology Research
2007 - | Belgian journal of botany
Joost Daemen, Patrick W. Serruys,
... dysfunctional endothelium was observed after both Cypher and Taxus implantation.25In the ENDEAVOR I and II trials, ... loss and binary restenosis rate compared with the Taxus stent.29BiolimusBiolimus A9 is a highly lipophilic sirolimus ... in the Biolimus arm as compared with the Taxus arm.31PimecrolimusAlthough a part of the Limus family, ... a member of the Limus family, the PES (Taxus, Boston Scientific, Natick, Mass) was the second DES ... and G2/M phases (Figure 1). The randomized TAXUS-I trial (2003) was designed as a FIM ...
Tópico(s): Antiplatelet Therapy and Cardiovascular Diseases
2007 - Lippincott Williams & Wilkins | Circulation
Esteban Escolar, Gary S. Mintz, Jeffrey J. Popma, Aleksandra Michałek, Sang‐Wook Kim, Lazar Mandinov, Joerg Koglin, Gregg W. Stone, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, Neil J. Weissman,
... stent population. A subset of patients from the TAXUS IV, V, and VI studies was evaluated. The subset, which included 216 TAXUS-treated patients and 191 bare-metal stent–treated ... parameters were consistent with less intimal hyperplasia in TAXUS patients than controls. The overall incidence of QCA ... was 14.0%, which was 9.3% in TAXUS-treated patients and 19% in bare-metal stent– ... neointimal hyperplasia for the combined group of patients (TAXUS + bare-metal stent), as well as for the TAXUS-treated and bare-metal stent–treated patients separately. ...
Tópico(s): Cerebrovascular and Carotid Artery Diseases
2007 - Elsevier BV | The American Journal of Cardiology
Daniel Garcı́a, Isabel Martínez, José Ramón Obeso,
... beneath heterospecific canopies, among the ornithochorous tree species Taxus baccata, Ilex aquifolium and Crataegus monogyna in temperate ... with a less-preferred species. Seed rain under Taxus canopies was dominated by Taxus seeds, which occurred in low proportion under heterospecific ... much higher for Ilex and Crataegus than for Taxus. The effects of seed rain composition on post-dispersal seed predation were species-specific. Taxus seeds experienced lower predation when occurring in a ... die Bereiche heterospezifischer Baumkronen, bei den ornithochoren Baumarten Taxus baccata, Ilex aquifolium und Crataegus monogyna in gemäßigten ...
Tópico(s): Animal Ecology and Behavior Studies
2007 - Elsevier BV | Basic and Applied Ecology
Mark Turco, John A. Ormiston, Jeffrey J. Popma, Lazar Mandinov, Charles O’Shaughnessy, Tift Mann, Thomas McGarry, Chiung‐Jen Wu, Charles Chan, Mark Webster, Jack Hall, Gregory Mishkel, Louis Cannon, Donald S. Baim, Joerg Koglin,
... to assess non-inferiority of the next-generation TAXUS Liberté stent (Boston Scientific Corp., Natick, Massachusetts) versus the TAXUS Express stent (Boston Scientific Corp.). The introduction of ... subsets, prompting the need for more deliverable DES. TAXUS Liberté was designed to combine the established polymer-based, paclitaxel-elution TAXUS technology with the more advanced Liberté stent platform. The TAXUS ATLAS study is a global, prospective, single-arm ... group is an entry-criteria-matched population of TAXUS Express patients from the TAXUS IV and V ...
Tópico(s): Aortic aneurysm repair treatments
2007 - Elsevier BV | Journal of the American College of Cardiology
Keiichi Tsuchida, Patrick W. Serruys, Nico Bruining, Dariusz Dudek, J Drzewiecki, Adrian Banning, Krzysztof Żmudka, François Schiele, Zheng Zhou, Tessa Rademaker, Gerrit-Anne van Es, Joerg Koglin, Mary E. Russell, Antonio Colombo,
... neointimal growth to measure restenotic plaque load in TAXUS and bare metal stents. The randomized TAXUS II trial evaluates the polymer-based paclitaxel-eluting TAXUS stent in slow- and moderate-release formulations. Serial ... 155 event-free patients (bare metal stent, 74; TAXUS stent, 81) after the procedure, at 6 months, ... in late loss and neointimal volume in the TAXUS versus the control group. From 6 months to ... demonstrating neointimal compaction over time. However, in the TAXUS group, QCA late loss showed a nonsignificant decrease ...
Tópico(s): Cerebrovascular and Carotid Artery Diseases
2007 - Elsevier BV | The American Journal of Cardiology
Qi Zhang, Ruiyan Zhang, Jiansheng Zhang, Jian Hu, Zhenkun Yang, Jun Ni, Yuehua Fang, Xian Zhang, Wei-feng Shen,
... stent (Cypher, Cordis, USA) or paclitaxel-eluting stent (Taxus, Boston Scientific, USA), in treatment of patients with ... high cost of imported DES (either Cypher or Taxus) gave the birth to a China-made, polymer- ... of Firebird stent in comparison with Cypher and Taxus stents are still underestimated. METHODS Patients From May ... group (n=224), Cypher group (n=246) and Taxus group (n=203). Major exclusive criteria included: ①without ... for at least 9 months). For those with Taxus stents, ticlopidine or clopidogrel was continued for at ...
Tópico(s): Antiplatelet Therapy and Cardiovascular Diseases
2006 - Lippincott Williams & Wilkins | Chinese Medical Journal
Yanai Ben‐Gal, Yaron Moshkovitz, Nachum Nesher, Gideon Uretzky, Rony Braunstein, Alberto Hendler, Einat Zivi, Itzhak Herz, Rephael Mohr,
... with bare-metal stents. Recent reports from the TAXUS IV (Boston Scientific Corp, Natick, MA) and SIRIUS ... J.B. Raizner A. Cannon L. et al.TAXUS-IV InvestigatorsOutcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus The TAXUS-IV trial.J Am Coll Cardiol. 2005; 45: ... J.B. Raizner A. Cannon L. et al.TAXUS-IV InvestigatorsOutcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus The TAXUS-IV trial.J Am Coll Cardiol. 2005; 45: ...
Tópico(s): Cardiac Valve Diseases and Treatments
2006 - Elsevier BV | The Annals of Thoracic Surgery
Stephen T. Russell, Fernando Antoñanzas, Vicente Mainar,
... a la utilización del stent liberador de fármaco Taxus frente a un stent convencional en el tratamiento ... Se ha simulado el resultado del ensayo clínico TAXUS IV en una población de riesgo similar y ... fue de 6.934 € en el caso de Taxus y de 6.756 € en el caso de ... de alto riesgo, la estrategia de tratamiento con Taxus fue menos costosa a los 12 meses (decremento ... 7%). Una estrategia de tratamiento generalizado con stent Taxus eleva ligeramente el impacto presupuestario, mientras que en ... cost impact associated with the utilization of the Taxus drug eluting stent versus a conventional bare-metal ...
Tópico(s): Pharmaceutical Economics and Policy
2006 - Elsevier BV | Revista Española de Cardiología
Donald S. Baim, Roxana Mehran, Dean J. Kereiakes, Thomas P. Gross, Michael Simons, David J. Malenka, Aaron V. Kaplan,
... eluting coronary stent (Cordis/Johnson & Johnson) and the Taxus paclitaxel-eluting coronary stent systems (Boston Scientific).Subacute ... label use to its occurrence.Nondeflation of the Taxus Stent Delivery Catheter BalloonThe Taxus paclitaxel-eluting coronary stent system (Taxus stent; Boston Scientific) was released in March 2004 ... the Cypher stent, the market release of the Taxus stent was an extraordinary success, with >200 000 ... with the FDA, Boston Scientific Inc voluntarily recalled Taxus stents from lots identified as the source of ...
Tópico(s): Cardiac Imaging and Diagnostics
2006 - Lippincott Williams & Wilkins | Circulation
Fernándo Alfonso, Javier Bermejo, Javier Segovia,
... a la utilización del stent liberador de fármaco Taxus frente a un stent convencional en el tratamiento ... Se ha simulado el resultado del ensayo clínico TAXUS IV en una población de riesgo similar y ... fue de 6.934 € en el caso de Taxus y de 6.756 € en el caso de ... de alto riesgo, la estrategia de tratamiento con Taxus fue menos costosa a los 12 meses (decremento ... 7%).Una estrategia de tratamiento generalizado con stent Taxus eleva ligeramente el impacto presupuestario, mientras que en ... cost impact associated with the utilization of the Taxus drug eluting stent versus a conventional bare-metal ...
Tópico(s): Antiplatelet Therapy and Cardiovascular Diseases
2005 - Elsevier BV | Revista Española de Cardiología